Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home, Multimodal Cognitive Assessment in People Living with ALS and FTD

Summary

Cumulus Neuroscience published results from the CNS-102 study in Scientific Reports demonstrating that its NeuLogiq® platform is feasible and usable for at-home cognitive assessment in patients with ALS and FTD, with high usability ratings from participants despite significant motor and cognitive impairment.